Effects of vatinoxan on cardiorespiratory function, fecal output and plasma drug concentrations in horses anesthetized with isoflurane and infusion of medetomidine

Show full item record



Permalink

http://hdl.handle.net/10138/306500

Citation

Tapio , H A , Raekallio , M R , Mykkänen , A K , Al-Ramahi , D , Scheinin , M , Hautajarvi , H J , Männikkö , S & Vainio , O 2019 , ' Effects of vatinoxan on cardiorespiratory function, fecal output and plasma drug concentrations in horses anesthetized with isoflurane and infusion of medetomidine ' , Veterinary Journal , vol. 251 , 105345 . https://doi.org/10.1016/j.tvjl.2019.105345

Title: Effects of vatinoxan on cardiorespiratory function, fecal output and plasma drug concentrations in horses anesthetized with isoflurane and infusion of medetomidine
Author: Tapio, H. A.; Raekallio, M. R.; Mykkänen, A. K.; Al-Ramahi, D.; Scheinin, M.; Hautajarvi, H. J.; Männikkö, S.; Vainio, O.
Contributor: University of Helsinki, Equine and Small Animal Medicine
University of Helsinki, Helsinki One Health (HOH)
University of Helsinki, Helsinki One Health (HOH)
University of Helsinki, Equine and Small Animal Medicine
Date: 2019-09
Language: eng
Number of pages: 6
Belongs to series: Veterinary Journal
ISSN: 1090-0233
URI: http://hdl.handle.net/10138/306500
Abstract: A constant rate infusion (CRI) of medetomidine is used to balance equine inhalation anesthesia, but its cardiovascular side effects are a concern. This experimental crossover study aimed to evaluate the effects of vatinoxan (a peripheral a2-adrenoceptor antagonist) on cardiorespiratory and gastrointestinal function in anesthetized healthy horses. Six horses received medetomidine hydrochloride 7 mu g/kg IV alone (MED) or with vatinoxan hydrochloride 140 mu g/kg IV (MED + V). Anesthesia was induced with midazolam and ketamine and maintained with isoflurane and medetomidine CRI for 60min. Heart rate, carotid and pulmonary arterial pressures, central venous pressure, cardiac output and arterial and mixed venous blood gases were measured. Selected cardiopulmonary parameters were calculated. Plasma drug concentrations were determined. Fecal output was measured over 24h. For statistical comparisons, repeated measures analysis of covariance and paired t-tests were applied. Heart rate decreased slightly from baseline in the MED group. Arterial blood pressures decreased with both treatments, but significantly more dobutamine was needed to maintain normotension with MED + V (P = 0.018). Cardiac index (CI) and oxygen delivery index (DO2I) decreased significantly more with MED, with the largest difference observed at 20min: CI was 39 +/- 2 and 73 +/- 18 (P = 0.009) and DO2I 7.4 +/- 1.2 and 15.3 +/- 4.8 (P = 0.014)mL/min/kg with MED and MED + V, respectively. Fecal output or plasma concentrations of dexmedetomidine did not differ between the treatments. In conclusion, premedication with vatinoxan induced hypotension, thus its use in anesthetized horses warrants further studies. Even though heart rate and arterial blood pressures remained clinically acceptable with MED, cardiac performance and oxygen delivery were lower than with MED + V. (C) 2019 The Authors. Published by Elsevier Ltd.
Subject: Anesthesia
Cardiovascular function
Horse
Medetomidine
Vatinoxan
CONSTANT RATE INFUSION
PERIPHERAL ALPHA-2-ADRENOCEPTOR ANTAGONIST
INTRAVENOUS DEXMEDETOMIDINE
ALPHA(2)-ADRENOCEPTOR ANTAGONIST
MK-467
DETOMIDINE
ANESTHESIA
ROMIFIDINE
HALOTHANE
XYLAZINE
413 Veterinary science
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S1090023319300802_main.pdf 417.0Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record